drugset / Trial / NCT03086291

A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy

NCT03086291

Phase 1 Unknown 9 enrolled Samsung Medical Center
NaSingle-groupOpen-labelTreatment

Summary

Simvastatin 5-10mg/kg bid for 7 days and 14 days off treatment for 21 days Cohort 1: 7.5 mg/kg bid for 7 days 14 days off Cohort 2: 10 mg/kg bid for 7 days 14 days off Cohort 3: ( ) mg/kg bid for 7 days 14 days off (to be determined based on PK data of cohort 1 and 2) Q 3 weeks

Timeline

Start
2018-01-04
Primary completion
2020-09
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 7.5 mg/kg
Subject Simvastatin Small molecule 10 mg/kg

Indications